CrystecPharma to attend PODD 2026 in Boston
Crystec CEO, Paul Thorning, to attend PODD.
CrystecPharma to attend PODD 2026 in Boston Read More »
Crystec Secures Funding to Accelerate Growth and Innovation
CrystecPharma is pleased to announce that we have secured a six-figure loan from Mercia to support the next phase of our growth.
Crystec Secures Funding to Accelerate Growth and Innovation Read More »
Dr Steven Nicholson Named a Finalist in the CPHI Pharma Awards 2026
Crystec’s Commercial Research Scientist, Steven Nicholson, has been named a finalist in the Future Leader category at the CPHI Pharma Awards 2026.
Dr Steven Nicholson Named a Finalist in the CPHI Pharma Awards 2026 Read More »
Crystec to attend the 14th MiBio Conference
CrystecPharma will attend MIBio 2026 in Cambridge to explore the latest advances in biopharmaceutical formulation, particle engineering and drug delivery.
Crystec to attend the 14th MiBio Conference Read More »
Crystec Welcomes New Marketing Executive Apprentice
We are delighted to welcome a new Marketing Executive Apprentice to the team
Crystec Welcomes New Marketing Executive Apprentice Read More »
Crystec to attend Climb 26
Crystec is pleased to be attending the ClimbUK Festival of Business Growth, taking place in Leeds on 1–2 July
Crystec to attend Climb 26 Read More »
Crystec to attend Malvern Panalytical’s 4th Annual Pharma Conference
Meet the Crystec team in Edgbaston on the 3rd of June
Crystec to attend Malvern Panalytical’s 4th Annual Pharma Conference Read More »
Dr Lyn Daintree Wins Outstanding Contribution Award at Making Pharmaceuticals Awards 2026
Multiple award winner Dr Lyn Daintree is recognised by Making Pharmaceuticals